Mayflower Financial Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Sell |
529
-4
| -0.8% | -$2.15K | 0.04% | 322 |
|
|
2025
Q1 | $224K | Buy |
533
+19
| +4% | +$7.98K | 0.03% | 359 |
|
|
2024
Q4 | $213K | Buy |
514
+17
| +3% | +$7.03K | 0.03% | 361 |
|
|
2024
Q3 | $251K | Sell |
497
-4
| -0.8% | -$2.02K | 0.04% | 318 |
|
|
2024
Q2 | $244K | Buy |
501
+4
| +0.8% | +$1.95K | 0.04% | 308 |
|
|
2024
Q1 | $268K | Buy |
497
+10
| +2% | +$5.4K | 0.04% | 292 |
|
|
2023
Q4 | $270K | Sell |
487
-3
| -0.6% | -$1.67K | 0.04% | 282 |
|
|
2023
Q3 | $214K | Buy |
490
+10
| +2% | +$4.37K | 0.03% | 309 |
|
|
2023
Q2 | $241K | Sell |
480
-4
| -0.8% | -$2.01K | 0.03% | 308 |
|
|
2023
Q1 | $242K | Buy |
+484
| New | +$242K | 0.03% | 300 |
|
|
2022
Q2 | – | Sell |
-493
| Closed | -$270K | – | 346 |
|
|
2022
Q1 | $270K | Buy |
493
+18
| +4% | +$9.86K | 0.04% | 292 |
|
|
2021
Q4 | $313K | Sell |
475
-2
| -0.4% | -$1.32K | 0.04% | 260 |
|
|
2021
Q3 | $306K | Buy |
477
+2
| +0.4% | +$1.28K | 0.04% | 258 |
|
|
2021
Q2 | $300K | Buy |
475
+6
| +1% | +$3.79K | 0.04% | 242 |
|
|
2021
Q1 | $229K | Sell |
469
-71
| -13% | -$34.7K | 0.03% | 262 |
|
|
2020
Q4 | $270K | Buy |
+540
| New | +$270K | 0.05% | 220 |
|